YDL223C powder is a solid form of the compound HBT1, also known as HBT1 powder, with a purity of up to 99%, and is primarily intended for research purposes in neuroscience. HBT1 is a potent α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor potentiator. It binds to the AMPA receptor's ligand binding domain (LBD) in a glutamate-dependent manner. It has been shown to enhance AMPA receptor activity with lower agonism than other AMPA-R potentiators. This property reduces the risk of a bell-shaped response in the production of brain-derived neurotrophic factor (BDNF), making it helpful in studying synaptic transmission and potential therapeutic effects on neuropsychiatric and neurological disorders.
HBT1 Function
HBT1 has several benefits primarily due to its role as an AMPA receptor potentiator. Here are some of the key benefits:
1. Cognitive Enhancement:
HBT1 can improve cognitive functions, including learning, memory, and overall mental performance. It enhances synaptic transmission, which is crucial for cognitive processes.
2. Neuroplasticity:
By potentiating AMPA receptors, HBT1 promotes synaptic plasticity, essential for the brain's ability to adapt and reorganize itself. Better learning and memory retention may result from this.
3. BDNF Production:
HBT1 enhances the production of brain-derived neurotrophic factor (BDNF), a protein that supports neurons' survival, growth, and differentiation. Increased BDNF levels are associated with better mental health and cognitive function.
4. Reduced Agonistic Effects:
Unlike other AMPA-R potentiators, HBT1 has lower agonistic effects, reducing the risk of excessive stimulation and potential side effects. This makes it a safer option for cognitive enhancement and potential therapeutic use.
5. Potential Therapeutic Uses:
Because HBT1 enhances synaptic function and neuroplasticity, it may be used to treat neuropsychiatric and neurological illnesses such as autism, schizophrenia, and Alzheimer's disease.
These benefits make HBT1 a promising compound for research in cognitive enhancement and treating various brain-related conditions.
What Is The Use Of AMPA
AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) refers to both a type of ionotropic glutamate receptor and the synthetic agonist that activates these receptors. The use of AMPA, particularly in the context of AMPA receptors, includes various critical physiological and research applications:
1. Synaptic Transmission:
Fast Excitatory Neurotransmission: AMPA receptors mediate fast synaptic transmission in the central nervous system. Activated by glutamate, they permit sodium (Na⁺) and, to a lesser degree, calcium (Ca²⁺) ions to enter the neuron, resulting in synaptic communication and rapid depolarization.
2. Neuroplasticity:
Learning and Memory: In synaptic plasticity processes including long-term potentiation (LTP) and long-term depression (LTD), AMPA receptors are essential. These processes are essential for learning and memory formation. The modulation of AMPA receptors can strengthen or weaken synaptic connections based on neural activity, contributing to the brain's adaptability.
3. Cognitive Enhancement:
Nootropics: Compounds that potentiate AMPA receptor activity, such as AMPA receptor modulators or positive allosteric modulators, are often researched for their potential to enhance cognitive functions, including memory, attention, and learning. They are interested in developing treatments for cognitive deficits associated with neurodegenerative diseases and mental health disorders.
4. Research Tool:
Neuroscience Research: AMPA and its analogs are widely used in neuroscience research to study the function of glutamate receptors, synaptic transmission, and neural plasticity. These studies help understand the underlying mechanisms of various neurological and psychiatric conditions.
5. Potential Therapeutic Applications:
Neuropsychiatric Disorders: There is ongoing research into the therapeutic potential of AMPA receptor modulators for treating conditions such as depression, schizophrenia, and autism. By enhancing synaptic transmission and plasticity, these compounds could alleviate symptoms and improve cognitive functions in affected individuals.
AMPA Receptor And NMDA Receptor
A. AMPA Receptors (α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors):
1. Function:
AMPA receptors are ionotropic receptors that mediate fast synaptic transmission in the central nervous system. In the brain, they are mostly in charge of excitatory neurotransmission.
The neurotransmitter glutamate activates these receptors, which results in an influx of sodium (Na⁺) and a trace quantity of calcium (Ca²⁺) ions and depolarization of the postsynaptic membrane.
2. Structure:
AMPA receptors have four subunits (GluA1, GluA2, GluA3, and GluA4). The combination of these subunits determines the receptor's properties.
The presence of the GluA2 subunit typically results in a calcium-impermeable receptor, while the absence of GluA2 leads to calcium permeability.
3. Role in Neuroplasticity:
AMPA receptors play a crucial role in synaptic plasticity, including long-term potentiation (LTP), essential for learning and memory.
Modulation of AMPA receptors can enhance or reduce synaptic strength, impacting cognitive functions.
B. NMDA Receptors (N-Methyl-D-Aspartate receptors):
1. Function:
Additionally ionotropic, NMDA receptors are essential for memory formation and synaptic plasticity. They are unique because they require both glutamate binding and membrane depolarization to activate.
When activated, NMDA receptors allow the flow of sodium (Na⁺) and calcium (Ca²⁺) ions into the neuron and potassium (K⁺) ions out of the neuron. The calcium influx is significant for initiating intracellular signaling pathways related to plasticity.
2. Structure:
NMDA receptors comprise multiple subunits, including NR1, NR2 (A-D), and NR3 (A and B). The subunit composition affects the receptor's properties, such as its conductance and kinetics.
These receptors have a unique requirement for co-agonists, such as glycine or D-serine, along with glutamate for activation.
3. Role in Synaptic Plasticity:
NMDA receptors are essential for LTP and long-term depression (LTD), which are mechanisms underlying synaptic plasticity.
Changes in synaptic strength result from the activation of several signaling pathways by the calcium influx through NMDA receptors, which supports the processes of learning and memory.
C. Key Differences
1. Activation Requirements:
AMPA Receptors: Activated solely by glutamate.
NMDA Receptors: Require both glutamate binding and membrane depolarization, as well as the presence of co-agonists like glycine or D-serine.
2. Ion Permeability:
AMPA Receptors: Primarily permeable to sodium (Na⁺) and, in some cases, calcium (Ca²⁺), depending on the presence of the GluA2 subunit.
NMDA Receptors: Permeable to sodium (Na⁺), calcium (Ca²⁺), and potassium (K⁺).
3. Role in Synaptic Plasticity:
AMPA Receptors: Directly mediate fast excitatory synaptic transmission and contribute to the initial phase of synaptic potentiation.
NMDA Receptors: Involved in synaptic plasticity mechanisms such as LTP and LTD, with calcium influx as a critical second messenger for intracellular signaling pathways.
If you want to know more about the YDL223C manufacturer, you can contact Xi'an Sonwu. Click the email to get a high-quality HBT1 powder.
Email: sales@sonwu.com